Dr. Berkay Simsek

Dr. Berkay Simsek is a research fellow in pathology at Brigham and Women’s Hospital.

Articles by Dr. Berkay Simsek

TAMs may help predict response to PD-1 inhibitors in metastatic clear cell kidney cancer, Dr. Berkay Simsek reported at the 2025 Kidney Cancer Summit.

What Can Influence Immunotherapy Responses in Kidney Cancer?

August 5th 2025

TAMs may help predict response to PD-1 inhibitors in metastatic clear cell kidney cancer, Dr. Berkay Simsek reported at the 2025 Kidney Cancer Summit.

Dr. Berkay Simsek

Articles by Dr. Berkay Simsek

What Can Influence Immunotherapy Responses in Kidney Cancer?

Latest Updated Articles

Trending on CURE

Brachytherapy, Chemo, and Turner Syndrome: A Teen's Rare Cancer Battle

FDA Grants Orphan Drug Designation to M2T-CD33 in AML

Top Gastrointestinal Cancer News: October 2025

Top Breast Cancer Stories from October 2025

Basal Cell Carcinoma Basics, From Diagnosis to Treatment